JP5422956B2 - 皮膚外用クリーム剤 - Google Patents
皮膚外用クリーム剤 Download PDFInfo
- Publication number
- JP5422956B2 JP5422956B2 JP2008249329A JP2008249329A JP5422956B2 JP 5422956 B2 JP5422956 B2 JP 5422956B2 JP 2008249329 A JP2008249329 A JP 2008249329A JP 2008249329 A JP2008249329 A JP 2008249329A JP 5422956 B2 JP5422956 B2 JP 5422956B2
- Authority
- JP
- Japan
- Prior art keywords
- cream
- terbinafine hydrochloride
- irritation
- external
- ester oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000006071 cream Substances 0.000 title claims description 28
- 229960000699 terbinafine hydrochloride Drugs 0.000 claims description 25
- 230000007794 irritation Effects 0.000 claims description 17
- 239000010696 ester oil Substances 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 14
- 239000007787 solid Substances 0.000 claims description 14
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims description 14
- 238000002156 mixing Methods 0.000 claims description 9
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 claims description 8
- 229940073665 octyldodecyl myristate Drugs 0.000 claims description 8
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 229940116364 hard fat Drugs 0.000 claims description 5
- NCLNAHJFXIKYBY-UHFFFAOYSA-N 2-hexyldecyl 16-methylheptadecanoate Chemical compound CCCCCCCCC(CCCCCC)COC(=O)CCCCCCCCCCCCCCC(C)C NCLNAHJFXIKYBY-UHFFFAOYSA-N 0.000 claims description 4
- 238000013329 compounding Methods 0.000 claims description 4
- 229940100611 topical cream Drugs 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 2
- DOMXUEMWDBAQBQ-WEVVVXLNSA-N terbinafine Chemical compound C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 DOMXUEMWDBAQBQ-WEVVVXLNSA-N 0.000 claims 5
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 description 22
- 238000002360 preparation method Methods 0.000 description 10
- 230000000052 comparative effect Effects 0.000 description 9
- 206010040880 Skin irritation Diseases 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 231100000475 skin irritation Toxicity 0.000 description 8
- 230000036556 skin irritation Effects 0.000 description 8
- 229940121375 antifungal agent Drugs 0.000 description 7
- 238000009472 formulation Methods 0.000 description 7
- 230000000638 stimulation Effects 0.000 description 6
- 241000283973 Oryctolagus cuniculus Species 0.000 description 5
- 238000010998 test method Methods 0.000 description 5
- 230000000843 anti-fungal effect Effects 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 3
- 229940121363 anti-inflammatory agent Drugs 0.000 description 3
- 239000002260 anti-inflammatory agent Substances 0.000 description 3
- 239000003429 antifungal agent Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- XMAYWYJOQHXEEK-ZEQKJWHPSA-N (2S,4R)-ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@H]1O[C@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-ZEQKJWHPSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 229960004194 lidocaine Drugs 0.000 description 2
- 239000003589 local anesthetic agent Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 201000009862 superficial mycosis Diseases 0.000 description 2
- 201000004647 tinea pedis Diseases 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- -1 2-hexyldecyl Chemical group 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 241000237858 Gastropoda Species 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229960001747 cinchocaine Drugs 0.000 description 1
- PUFQVTATUTYEAL-UHFFFAOYSA-N cinchocaine Chemical compound C1=CC=CC2=NC(OCCCC)=CC(C(=O)NCCN(CC)CC)=C21 PUFQVTATUTYEAL-UHFFFAOYSA-N 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940126534 drug product Drugs 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 208000024386 fungal infectious disease Diseases 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- NFLGAXVYCFJBMK-UHFFFAOYSA-N isomenthone Natural products CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 description 1
- 229960004125 ketoconazole Drugs 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 229940064438 nizoral Drugs 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229960004919 procaine Drugs 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000002884 skin cream Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
Images
Landscapes
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
(1)塩酸テルビナフィン、低極性液体エステル油及び固形トリグリセリドを配合することを特徴とする外用クリーム剤、
(2)固形トリグリセリドがハードファットである(1)記載の外用クリーム剤、
(3)低極性液体エステル油がミリスチン酸オクチルドデシル及びイソステアリン酸2−ヘキシルデシルから選ばれる1種又は2種である(1)又は(2)に記載の外用クリーム剤、
(4)塩酸テルビナフィンの配合量が外用クリーム剤全体の0.2〜2質量%である(1)〜(3)のいずれかに記載の外用クリーム剤、
(5)低極性液体エステル油及び固形トリグリセリドを含有する塩酸テルビナフィンの刺激低減剤、
(6)塩酸テルビナフィン配合外用クリーム剤において、低極性液体エステル油及び固形トリグリセリドを配合してクリーム剤を製造することを特徴とする塩酸テルビナフィンの刺激を低減する方法、である。
実施例
表1−1〜1−4に示した処方で、常法により実施例1〜12及び比較例1〜5のクリーム剤を得た。
(試験方法)
毛を刈ったウサギ背部皮膚に製剤0.1gを、1日1回所定の期間連続塗布し、各塗布の24時間後に製剤をふき取り、皮膚変化を毎日観察した。判定は紅斑及び浮腫形成を以下の表に示したDraizeの判定基準に従い行った。紅斑及び浮腫形成の各スコアの合計を刺激スコアとした。
塩酸テルビナフィン1%含有市販品クリーム剤と比較例1を上記試験方法により試験した。期間は、14日間観察した。
比較例1〜4を上記試験方法により試験した。期間は、10日間観察した。
比較例1及び5を上記試験方法により試験した。期間は、28日間観察した。
実施例2、比較例1及び比較例4を上記試験方法により試験した。期間は、28日間観察した。
Claims (6)
- 塩酸テルビナフィン、IOB値0.1未満である常温(25℃)で液体のエステル油及び固形トリグリセリドを配合することを特徴とする外用クリーム剤。
- 固形トリグリセリドがハードファットである請求項1記載の外用クリーム剤。
- IOB値0.1未満である常温(25℃)で液体のエステル油がミリスチン酸オクチルドデシル及びイソステアリン酸2−ヘキシルデシルから選ばれる1種又は2種である請求項1又は2に記載の外用クリーム剤。
- 塩酸テルビナフィンの配合量が外用クリーム剤全体の0.2〜2質量%である請求項1〜3のいずれかに記載の外用クリーム剤。
- IOB値0.1未満である常温(25℃)で液体のエステル油及び固形トリグリセリドを含有する塩酸テルビナフィンの刺激低減剤。
- 塩酸テルビナフィン配合外用クリーム剤において、IOB値0.1未満である常温(25℃)で液体のエステル油及び固形トリグリセリドを配合してクリーム剤を製造することを特徴とする塩酸テルビナフィンの刺激を低減する方法。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008249329A JP5422956B2 (ja) | 2007-10-01 | 2008-09-27 | 皮膚外用クリーム剤 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007257015 | 2007-10-01 | ||
JP2007257015 | 2007-10-01 | ||
JP2008249329A JP5422956B2 (ja) | 2007-10-01 | 2008-09-27 | 皮膚外用クリーム剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2009102310A JP2009102310A (ja) | 2009-05-14 |
JP5422956B2 true JP5422956B2 (ja) | 2014-02-19 |
Family
ID=40704452
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008249329A Active JP5422956B2 (ja) | 2007-10-01 | 2008-09-27 | 皮膚外用クリーム剤 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5422956B2 (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103386058A (zh) * | 2013-07-02 | 2013-11-13 | 袁娟 | 一种治疗体股癣的药物以及制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09309827A (ja) * | 1996-05-22 | 1997-12-02 | Pola Chem Ind Inc | 抗真菌外用剤 |
TWI248369B (en) * | 2001-02-28 | 2006-02-01 | Neopharm Co Ltd | Multi-lamellar emulsion for stabilizing dermatologically useful ingredients and external preparation utilizing the same |
JP2005104924A (ja) * | 2003-09-30 | 2005-04-21 | Kobayashi Pharmaceut Co Ltd | 外用医薬組成物 |
JP5019724B2 (ja) * | 2005-07-01 | 2012-09-05 | ロート製薬株式会社 | 抗真菌医薬組成物 |
-
2008
- 2008-09-27 JP JP2008249329A patent/JP5422956B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
JP2009102310A (ja) | 2009-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI240635B (en) | Active vitamin D3 emulsion lotion | |
US6911211B2 (en) | Pharmaceutical and cosmetic carrier or composition for topical application | |
TW570807B (en) | Oil-in-water type emulsified composition | |
MX2014002718A (es) | Composicion para el alivio del dolor, que comprende un agonista selectivo de trpv1, y manufactura y usos de la misma. | |
JP2009184951A (ja) | 皮膚外用剤組成物 | |
EP3656444A1 (en) | Stabilized oil-in-water emulsion | |
JP2017525701A (ja) | 経鼻適用のためのシネオール含有組成物 | |
CN106456522B (zh) | 用于个人卫生的制剂 | |
JP6646390B2 (ja) | 外用組成物 | |
JP2016169188A (ja) | 皮膚外用剤 | |
JP5422956B2 (ja) | 皮膚外用クリーム剤 | |
EP2155158B1 (en) | Personal lubricant composition | |
KR102253063B1 (ko) | 스틱형 통증완화 조성물 및 그 제조방법 | |
JP2010120909A (ja) | 外用塗布剤、外用塗布クリーム及び外用塗布ジェル | |
WO2013133062A1 (ja) | アレルギー性鼻炎用塗付剤 | |
JP6903411B2 (ja) | 外用組成物 | |
JP5507146B2 (ja) | 油中水型乳化ペースト状口唇用医薬品製剤 | |
JP7086597B2 (ja) | 外用組成物 | |
JP5063072B2 (ja) | 皮膚外用組成物 | |
JP2008120775A (ja) | 皮膚外用剤 | |
JP6929339B2 (ja) | 外用組成物 | |
JP5565995B2 (ja) | 鎮痒剤 | |
JP2009167139A (ja) | 外用組成物 | |
JP5722364B2 (ja) | 医薬組成物 | |
KR102184802B1 (ko) | 저온 안정성이 개선된 플루로닉 레시틴 오르가노겔 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RD07 | Notification of extinguishment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7427 Effective date: 20090624 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20110912 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130521 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130712 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20131029 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20131111 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 Ref document number: 5422956 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |